COMPUGEN LTD
COMPUGEN LTD is a Healthcare company operating in Biotechnology with a $195.8M market cap.
Most recent earnings call: Q1 FY26 on May 18, 2026.
19 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks CGEN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 5/10 quarters with 20% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CGEN.
$ curl https://api.spokenalpha.com/v1/companies/CGENFAQ
Spoken Alpha indexes CGEN's earnings call transcripts at https://spokenalpha.com/companies/CGEN. Each call links to attributed speakers and parsed analyst Q&A. COMPUGEN LTD's own investor relations page is at https://cgen.com/investors-and-media/financials/quarterly-results-annual-reports-and-proxy/default.aspx.
COMPUGEN LTD (CGEN) held its most recent earnings call on 2026-05-18, covering fiscal Q1 2026.
COMPUGEN LTD (CGEN) operates in the Healthcare sector (Biotechnology industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.31 | $2.12 | +8.9% | +2.9% | +5.8% |
| Q4 FY2026 | $2.27 | $2.08 | +9.3% | -7.7% | -8.7% |
| Q3 FY2026 | $2.15 | $2.29 | -6.0% | -0.5% | -1.3% |
| Q2 FY2026 | $2.35 | $2.41 | -2.5% | -7.9% | -10.8% |
| Q1 FY2025 | $2.58 | $2.42 | +6.7% | -3.1% | -3.2% |
| Q4 FY2025 |
| $2.33 |
| $2.27 |
| +2.6% |
| -2.1% |
| -0.6% |
| Q3 FY2025 | $2.34 | $2.21 | +5.9% | -3.2% | -0.8% |
| Q2 FY2025 | $2.36 | $2.48 | -4.8% | +2.8% | +3.0% |
| Q1 FY2024 | $2.27 | $2.33 | -2.4% | -6.4% | -8.2% |
| Q4 FY2024 | $2.31 | $2.33 | -0.9% | -8.1% | -5.2% |